Alnylam Pharmaceuticals
ALNY
#640
Rank
NZ$56.26 B
Marketcap
$434.63
Share price
-1.30%
Change (1 day)
76.81%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company